Clinical Trial Update: Evaluation of VEGF Polymorphism as Predictive Factor in Metastatic Colorectal Cancer Treated With Folfiri Plus Bevacizumab

View source ↗

Summary

This clinical trial update discusses evaluating VEGF polymorphisms as a predictive factor for treatment response in metastatic colorectal cancer patients treate…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Bevacizumab (bevacizumab)
• Irinotecan (Irinotecan)
• Leucovorin (folinic acid)

Snippet

Sponsor: Azienda Ospedaliero, Universitaria Pisana | Conditions: Metastatic Colorectal Cancer | Status: UNKNOWN